Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine-based induction followed by haploidentical stem cell transplantation in therapy-resistant leukemia
2009-012437-30Phase 2Active
- Sponsor
- Skåne University Hospital
- Start
- Apr 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of clofarabine in leukemia, sponsored by Skåne University Hospital. Primary endpoint: Number of patients bridged to transplant with CLoEC induction. Started Apr 2010; status: active.
02
Drugs
clofarabine
03
Conditions
leukemia
Beyond the preview
Go deeper on 2009-012437-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012437-30.